Medidata, a global provider of cloud-based solutions for clinical research in life sciences, announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals, an oncology-focused biotechnology company. ASLAN’s will be using the Medidata Clinical Cloud™ to support the company’s strategy of maximizing the value of its in-licensed drug portfolio by conducting clinical development in Asia.

News

Medidata announced that it has signed an enterprise agreement with ASLAN Pharmaceuticals